Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 612 of 1,261
  1. US 9744226

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  2. US 9744169

    Compounds for treatment of fibrosis diseases

    Curegenix, Inc. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  3. US 9744159

    Methods of treatment Rett syndrome

    OVID THERAPEUTICS INC. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  4. US 9744146

    Method for alleviating disturbance of bile acid metabolism, amino acid metabolism, and/or gut microbiota metabolism

    China Medical University · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  5. US 9744194

    Methods of treating ischemic spasticity

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  6. US 9744132

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  7. US 9744126

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  8. US 9745585

    RNAi-mediated inhibition of histamine receptor H1-related conditions

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  9. US 9745576

    RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

    BIOMARIN TECHNOLOGIES B.V. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  10. US 9745572

    Method for identifying antibiotic targets

    DISCUVA LIMITED · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  11. US 9737640

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  12. US 9738724

    Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  13. US 9738678

    Substituted nucleoside derivatives with antiviral and antimicrobial properties

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  14. US 9738703

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  15. US 9738670

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  16. US 9738669

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  17. US 9737691

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  18. US 9738624

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  19. US 9737600

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  20. US 9737564

    Citrate containing beverage

    The Regents of the University of California · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  21. US 9737554

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  22. US 9737546

    Small molecules to enhance P53 activity

    The Regents of the University of California · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  23. US 9737560

    Process for preparation of a humic substance based gel for targeted external application

    BlackBalm, LLC · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  24. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.